Form 4: Arcellx CFO Sells Shares Under 10b5-1 Plan

Arcellx, Inc.'s Chief Financial Officer, Michelle Gilson, sold 5,364 shares of common stock for approximately $91.04 per share under a pre-arranged 10b5-1 trading plan.

Summary

• Michelle Gilson, Chief Financial Officer of Arcellx, Inc., reported a sale of common stock.
• The transaction involved 5,364 shares of Arcellx, Inc. common stock.
• The shares were sold at a weighted average price of $91.0357 per share, within a range of $90.99 to $91.19.
• The sale was executed on October 15, 2025.
• This transaction was conducted pursuant to a Rule 10b5-1 trading plan established by Ms. Gilson on March 21, 2025.
• Following the sale, Ms. Gilson directly beneficially owns 8,466 shares of Arcellx, Inc. common stock.

Sentiment

Score: 5

Explanation: Neutral. The transaction is a pre-planned insider sale under a 10b5-1 plan, which typically indicates a scheduled liquidity event rather than a reaction to company performance. While insider sales can sometimes be viewed negatively, the 10b5-1 plan mitigates this perception.

Negatives

• An insider sale, even if pre-planned, can sometimes be perceived negatively by the market as it reduces management's direct equity stake in the company.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: The sale by a CFO, even if pre-planned, might be scrutinized by investors, though the 10b5-1 plan generally reduces concerns about opportunistic selling. It slightly reduces management's direct equity alignment.

Key Dates

Recommendation

The filing reports a routine, pre-scheduled insider sale under a 10b5-1 plan. This type of transaction is typically for personal financial planning and does not usually signal a change in the company's fundamental outlook or warrant a change in investment recommendation based solely on this filing. Investors should continue to hold and evaluate the company based on its operational performance and broader market conditions.

Keywords

Arcellx, ACLX, Michelle Gilson, CFO, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Beneficial Ownership